您的位置: 首页 > 农业专利 > 详情页

Isoxazolinas as therapeutic agents
专利权人:
ABBOTT LABORATORIES
发明人:
CALDERWOOD DAVID J.,BREINLINGER ERIC C.,SWANN STEVEN L.,MUKHERJEE SUBHENDU,CHITTY VENKATA SRIKANTH,THUNUGUNTLA SIVA SANJEEVA RAO,HOSAHALLI SUBRAMANYAH SEETHARAMA SHASTRY
申请号:
ARP120101453
公开号:
AR086113A1
申请日:
2012.04.26
申请国别(地区):
AR
年份:
2013
代理人:
摘要:
The compounds of the present are useful to treat immunological conditions.Claim 1: wherein is a compound of formula (1), Biologically Active metabolites, prodrugs, isomers, stereoisomers, pharmaceutically acceptable Salts and solvates, hydrates of the same, which is selected from the group of formulas (2); X is a Ring System OPC Ionalmente substituted AromaticPartially Aromatic or non Aromatic systems with one or more Rings and is optionally substituted heteroaryl FUSED;; Z is nrcrd, - C (o) - C (o) - OCH3, nrcrd alkyl, optionally substituted cycloalkyl C1 - C3 - 6, 6 optionally substituted, optionally substituted aryl, heteroaryl option At present, replaced or optionally substituted heterocycle; ra is independently h,C1-3 alkyl or cycloalkyl, optionally substituted C3 6 optionally substituted; RB is independently h, CF3, c1-3 alkyl or cycloalkyl, optionally substituted C3 6 optionally substituted; RC and Rd is H is H or alkyl, optionally substituted C1 - 6; or RC and Rd, along with the N Atom Itr u00f3geno which are United to form a saturated or unsaturated Heterocyclic Ring System.Aromatic or non Aromatic 5 or 6 members; r1 is independently h, prays, BR, CL, F, c1-3 alkyl or cycloalkyl, optionally substituted C3 6 optionally substituted; RZ is H, alkyl or cycloalkyl, optionally substituted 3 C1 - C3 - 6 optionally substituted; M is 0, 1 or 2; n is 0, 1, 2 or 3; and P is 0, 1, 2 or 3; with the condition that when and pyridinyl,Is not replaced with phenyl optionally substituted.Los compuestos de la presente son útiles para tratar condiciones inmunológicas.Reivindicación 1: Un compuesto caracterizado porque es de fórmula (1), metabolitos biológicamente activos, prodrogas, isómeros, estereoisómeros, solvatos, hidratos y sales farmacéuticamente aceptables del mismo, donde A es seleccionado del grupo de formulas (2); X es un sistema de anillos opcionalmente sustituido que es aromático, parcialmente aromático o no aromático con uno o más sistemas de anillos fusionados; Y
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充